HK Stock Market Move | KINGBOARD HLDG (00148) rose nearly 5%, expecting a more than 4% year-on-year increase in mid-term net profit, with a significant growth in profits from the copper-clad laminate division.
Kinto Group (00148) rose nearly 5%. As of the time of writing, it increased by 4.85%, reaching HKD 41.12, with a transaction volume of HKD 727 million.
KINGBOARD HLDG (00148) rose nearly 5%. As of the time of this report, it has increased by 4.85%, trading at HKD 41.12, with a turnover of HKD 727 million.
In the news, KINGBOARD HLDG recently announced that the group expects its net profit for the six months ending June 30, 2026, to exceed HKD 2.7 billion, which is an increase of about 4% compared to the same period in 2025. The announcement stated that the significant growth of over 200% in the reported segment profit from the groups copper-clad laminates compared to the same period in 2025 is expected to result in an increase in the groups reported net profit during the reporting period, although this is partially offset by reported losses in the groups investment business during this period.
The market for copper-clad laminates and their upstream materials, including electronic glass fiber yarn, electronic glass fiber cloth, and copper foil, continues to experience strong demand, leading to a noticeable increase in the unit prices of the groups copper-clad laminate and upstream material products, along with a growth in the sales volume of copper-clad laminates compared to 2025. Currently, the supply shortage of electronic glass fiber yarn, electronic glass fiber cloth, copper foil, and copper-clad laminates is becoming more severe. The Board of Directors of Kingboard believes that the growth in net profit is also attributed to the groups strong and comprehensive vertical integration business model.
Related Articles

LEE & MAN PAPER (02314) announced its interim results, with a profit attributable to shareholders of HKD 1.373 billion, an increase of 69.28% year-on-year.

Hefei Lifeon Pharmaceutical (003020.SZ): Two products are expected to be selected for the national centralized procurement of medicines.

Shandong Keyuan Pharmaceutical (301281.SZ): Two products are expected to be selected in the national centralized drug procurement.
LEE & MAN PAPER (02314) announced its interim results, with a profit attributable to shareholders of HKD 1.373 billion, an increase of 69.28% year-on-year.

Hefei Lifeon Pharmaceutical (003020.SZ): Two products are expected to be selected for the national centralized procurement of medicines.

Shandong Keyuan Pharmaceutical (301281.SZ): Two products are expected to be selected in the national centralized drug procurement.

RECOMMEND





